Precision Cardiac Screenings Offer New Opportunities to Identify At-Risk Patients and Target Care
Diagnostic yield in larger gene panel testing, ambitious goals for gene editing, and gauging demand for genetic testing in the community.
Cardiology
Washington University Researchers Explore New Direction in Cardiometabolic Precision Medicine Screening
By detailing molecular biomarkers and traits, such as DNA methylation, gene expression, and metabolites, this study could reveal opportunities for early intervention in the cardiometabolic disease process.